Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: FCP
  • Objective: European Region
  • Asset Class: Equity
  • Geographic Focus: European Region

UBS Lux Equity Fund - European Opportunity EUR

+ Add to Watchlist

UBSLEBP:LX

195.51 EUR 1.08 0.56%

As of 00:59:30 ET on 05/21/2015.

Snapshot for UBS Lux Equity Fund - European Opportunity EUR (UBSLEBP)

Year To Date: +21.46% 3-Month: +7.87% 3-Year: +24.50% 52-Week Range: 147.64 - 196.86
1-Month: +0.03% 1-Year: +26.39% 5-Year: +15.85% Beta vs LUXXX: 0.79

Mutual Fund Chart for UBSLEBP

No chart data available.
  • UBSLEBP:LX 195.51
  • 1M
  • 1Y
Interactive UBSLEBP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for UBSLEBP

UBS (Lux) Equity Fund - European Opportunity (EUR) is an open-end investment fund incorporated in Luxembourg. The fund is actively managed based on a concentrated equity portfolio that invests in selected european companies. Fund aims to seek the best opportunities in the market based on various sources.

Inception Date: 06-23-2008 Telephone: 352-44-10-10-1 Tel
Managers: JEREMY LEUNG / MAXIMILIAN ANDERL
Web Site: www.ubs.com

Fundamentals for UBSLEBP

NAV (on 2015-05-21) 195.51
Assets (M) (on 2015-05-21) 1,115.72
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for UBSLEBP

No dividends reported

Fees & Expenses for UBSLEBP

Front Load 2.00
Back Load -
Current Mgmt Fee 0.82
Redemption Fee -
12b1 Fee -
Expense Ratio 1.06

Top Fund Holdings for UBSLEBP

Filing Date: 03/31/2015
Name Position Value % of Total
Novartis AG 926,680 85,412,495 7.831%
Bayer AG 307,916 43,092,844 3.951%
Nestle SA 472,628 33,255,068 3.049%
AstraZeneca PLC 515,491 32,964,734 3.022%
Unilever NV 838,197 32,618,436 2.991%
Novo Nordisk A/S 650,359 32,384,130 2.969%
Sampo Oyj 652,965 30,702,414 2.815%
Aviva PLC 4,004,997 29,893,163 2.741%
Reckitt Benckiser Group PLC 347,354 27,846,859 2.553%
Pernod Ricard SA 246,375 27,138,206 2.488%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil